135 results on '"A. Baruchel"'
Search Results
2. Leukaemic transformation in a 10‐year‐old girl with <scp> SRP54 </scp> congenital neutropenia
3. Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia?
4. Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia?
5. Leukaemic transformation in a 10‐year‐old girl withSRP54congenital neutropenia
6. Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective study
7. Leukaemic transformation in a 10‐year‐old girl with SRP54 congenital neutropenia.
8. Infant T‐cell acute lymphoblastic leukaemia with t(6;7) ( TCRB‐MYB ) translocation
9. Managing children with chronic myeloid leukaemia (CML): Recommendations for the management of CML in children and young people up to the age of 18 years
10. Relationship between cytomegalovirus (CMV) reactivation, CMV-driven immunity, overall immune recovery and graft-versus-leukaemia effect in children
11. Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study
12. Absence of SBDS mutations in sporadic paediatric acute myeloid leukaemia
13. CBL mutations do not frequently occur in paediatric acute myeloid leukaemia
14. Primary mediastinal large B-cell lymphoma in Pediatric Patients (PMBCL): a retrospective analysis and outcome after LMB 89-96- 2001 SFOP- SFCE protocols, with and without rituximab: 37
15. l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial
16. Outcome of children treated with haematopoietic-stem cell transplantations from donors expressing the rare C77G variant of the PTPRC (CD45) gene
17. Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22 ‐positive B‐cell acute lymphoblastic leukaemia
18. Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia
19. Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemia
20. Differences in cyto- and molecular genetic aberrations between children o2 years and older children with acute myeloid leukaemia: 6
21. Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines
22. PHF6mutations in paediatric acute myeloid leukaemia
23. The effect of age in patients with acquired aplastic anaemia treated with immunosuppressive therapy: comparison of Adolescents and Young Adults with children and older adults
24. The effect of age in patients with acquired aplastic anaemia treated with immunosuppressive therapy: comparison of Adolescents and Young Adults with children and older adults
25. Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables
26. The majority of myeloid-antigen-positive (My sup +) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcripts
27. A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies
28. Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detection
29. Managing children with chronic myeloid leukaemia (CML)
30. An effective modestly intensive re-induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemia
31. Impact of therapy in a cohort of unselected children with Down Syndrome-associated Acute Lymphoblastic Leukaemia
32. l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial
33. Outcome of children treated with haematopoietic-stem cell transplantations from donors expressing the rare C77G variant of the PTPRC (CD45) gene
34. Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia
35. Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective study
36. Relationship between cytomegalovirus (CMV) reactivation, CMV-driven immunity, overall immune recovery and graft-versus-leukaemia effect in children
37. Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines
38. PHF6mutations in paediatric acute myeloid leukaemia
39. Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables
40. Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study
41. A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies
42. Absence of SBDS mutations in sporadic paediatric acute myeloid leukaemia
43. Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detection
44. Impact of therapy in a cohort of unselected children with Down Syndrome-associated Acute Lymphoblastic Leukaemia
45. Systematic review of the addition of vincristine plus steroid pulses in maintenance treatment for childhood acute lymphoblastic leukaemia - an individual patient data meta-analysis involving 5659 children
46. Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemia
47. PHF6 mutations in paediatric acute myeloid leukaemia.
48. Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study group
49. The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcripts
50. Absence ofSBDSmutations in sporadic paediatric acute myeloid leukaemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.